These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18382390)

  • 81. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 82. [Functional rheography in early diagnosis of obliterating diseases of arteries of the lower limbs].
    Lushchenko SM; Kharchenko VG; Pisarenko AS
    Klin Khir (1962); 1975 Oct; (10):33-6. PubMed ID: 1214343
    [No Abstract]   [Full Text] [Related]  

  • 83. [Lumbar sympathectomy in atherosclerosis obliterance of lower limb arteries and age of the patients].
    Kokhan EP; Pinchuk OV; Kokhan VE
    Khirurgiia (Mosk); 2000; (11):41-3. PubMed ID: 11220918
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Low intensity laser radiation in complex therapy of patients with vascular obliterating atherosclerosis of low extremities].
    Klimenko IT; Shuvalova IN
    Lik Sprava; 2002; (8):98-102. PubMed ID: 12669557
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Evaluation of the correlation between impedance rheography data, function tests and basic laboratory studies in patients with arteriosclerosis obliterans of the lower extremities].
    Lukjan H; Dabrowski S; Bielawiec M
    Kardiol Pol; 1985; 28(12):776-83. PubMed ID: 3835378
    [No Abstract]   [Full Text] [Related]  

  • 86. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 87. [Interpretation of rheography of the lower extremities in chronic peripheral arteriopathies in correlation with the serial angiographic study].
    Giardino C; Marcialis A; Tardio B; Sica GS
    G Ital Chir; 1966 Nov; 22(6):807-53. PubMed ID: 5996936
    [No Abstract]   [Full Text] [Related]  

  • 88. [CONTRIBUTION TO SEMEIOLOGY OF THE OBLITERATING ARTERIOPATHIES OF THE LEGS (COMPARATIVE SPHYGMO-RHEOGRAPHIC AND ANGIOGRAPHIC FINDINGS)].
    PAGLIANI G; BERARDI P
    Arch Med Interna; 1963 Dec; 15():275-97. PubMed ID: 14215169
    [No Abstract]   [Full Text] [Related]  

  • 89. [Long-term results of dyslipoproteinemia surgical correction in patients with obliterating atherosclerosis of the lower extremity].
    Sedov VM; Mirchuk KK; Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 2010; 169(1):101-7. PubMed ID: 20387617
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Basic principles and approaches to medical rehabilitation of patients with atherosclerosis obliterans of lower limb arteries].
    Knyazeva TA; Badtieva VA; Trukhacheva NV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(4):54-61. PubMed ID: 34380305
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [ANGIOGRAPHIC EXAMINATION OF THE MAJOR ARTERIES OF THE LOWER EXTREMITIES IN ATHEROSCLEROSIS].
    DULAEV SG
    Zdravookhr Beloruss; 1963 Jun; 9():28-30. PubMed ID: 14078494
    [No Abstract]   [Full Text] [Related]  

  • 92. Angiographic findings in Buerger disease.
    Suzuki S; Yamada I; Himeno Y
    Int J Cardiol; 1996 Aug; 54 Suppl():S189-95. PubMed ID: 9119523
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Immediate and long-term results of the use of plasmapheresis in obliterating atherosclerosis of the vessels of the lower limbs].
    Kliachkin ML; Marchenko VB
    Kardiologiia; 1990 Aug; 30(8):7-10. PubMed ID: 2255149
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T; Motomiya T; Isokane N; Shimamoto T
    Jpn Heart J; 1971 Jul; 12(4):335-46. PubMed ID: 5314713
    [No Abstract]   [Full Text] [Related]  

  • 95. [The loss of work fitness and the course of invalidism in patients with limb vessel lesions].
    Chernenko VF; Goncharenko AG; Shuvalov AIu; Chernenko VV; Tarasov IV
    Angiol Sosud Khir; 2005; 11(2):21-7. PubMed ID: 16037799
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
    Urabe Y; Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Am J Cardiol; 1993 Jul; 72(2):218-22. PubMed ID: 8328387
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract]   [Full Text] [Related]  

  • 98. Factor VIII and antithrombin III in atherosclerosis obliterans of the lower limbs.
    Avellone G; Mandalà V; Novo S; Pinto A; Riolo FP; Cannioto F; Raneli G
    Adv Exp Med Biol; 1984; 164():65-80. PubMed ID: 6421107
    [No Abstract]   [Full Text] [Related]  

  • 99. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
    Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
    Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
    Shimamoto T; Atsumi T; Yamashita S; Motomiya T; Isokane N; Ishioka T; Sakuma A
    Am Heart J; 1970 Jan; 79(1):5-19. PubMed ID: 4903137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.